Beta-containing COVID-19 booster vaccine found to cross-neutralize
A new paper presents preliminary evidence that a new vaccine candidate, designed to boost immunity in already immunized individuals, and containing the adjuvanted Beta spike variant protein antigen, can induce a potent cross-neutralizing antibody response in non-human primate models that is detectable for up to three months.
:max_bytes(150000):strip_icc()/brano-QSuou3VAtf4-unsplash-de657fc5880046b493909ea2e02262dc.jpeg)
COVID-19 Booster Shots: Are They Variant-Specific?
Neutralization of SARS-CoV-2 variants by NVX-CoV2373 vaccinee plasma.
Sinopharm BIBP COVID-19 vaccine - Wikipedia
Boosting with updated COVID-19 mRNA vaccines
The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants - ScienceDirect
Dean Huang's Instagram, Twitter & Facebook on IDCrawl
Frontiers Association of fat-soluble vitamins (A, D, and E) status with humoral immune response to COVID-19 inactivated vaccination
WHO advisers recommend sticking with monovalent COVID XBB.1.5 vaccines
JCM, Free Full-Text
ACE2 – NIH Director's Blog
Beta-containing COVID-19 booster vaccine found to cross-neutralize variants in non-human primates
Moderna COVID-19 vaccine - Wikipedia
Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization - ScienceDirect
A new variant alert - by Eric Topol - Ground Truths
